20th Sep 2016 12:55
|
| ||||
|
| ||||
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES | |||||
|
| ||||
1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii | AA plc | ||||
2 Reason for the notification (please tick the appropriate box or boxes): | |||||
An acquisition or disposal of voting rights | √ | ||||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | √ | ||||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
| ||||
An event changing the breakdown of voting rights |
| ||||
Other (please specify): |
|
| |||
3. Full name of person(s) subject to thenotification obligation: iii | Aviva plc & its subsidiaries | ||||
4. Full name of shareholder(s) (if different from 3.):iv | Registered Holder:
BNY Norwich Union Nominees Limited 1,250,049*
Chase (GA Group) Nominees Limited 17,418,693*
Chase Nominees Limited 238,576*
State Street Nominees Limited 590,747*
*denotes direct interest
| ||||
5. Date of the transaction and date onwhich the threshold is crossed orreached: v | 16 September 2016 | ||||
6. Date on which issuer notified: | 19 September 2016 | ||||
7. Threshold(s) that is/are crossed orreached: vi, vii | 4% to 3% Change at Direct Interest Level (Box 8A & 8B) | ||||
8. Notified details: | ||||||||||
A: Voting rights attached to shares viii, ix | ||||||||||
Class/type ofshares if possible usingthe ISIN CODE | Situation previousto the triggeringtransaction | Resulting situation after the triggering transaction | ||||||||
NumberofShares | NumberofVotingRights | Numberof shares | Number of votingrights | % of voting rights x | ||||||
Direct | Direct xi | Indirect xii | Direct | Indirect | ||||||
Ordinary Shares
GB00BMSKPJ95
| 25,275,664* | 25,275,664* | 19,498,065 | 19,498,065 | Not disclosable | 3.20% | Not disclosable | |||
| ||||||||||
* Includes right to recall loaned shares (1,122,678)
| ||||||||||
B: Qualifying Financial Instruments | ||||||||||
Resulting situation after the triggering transaction | ||||||||||
Type of financialinstrument | Expirationdate xiii | Exercise/Conversion Period xiv | Number of votingrights that may beacquired if theinstrument isexercised/ converted. | % of votingrights | ||||||
RIGHT TO RECALL LOANED SHARES | N/A | N/A | 4,027,063*
*Direct interest | 0.66% | ||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi | ||||||
Resulting situation after the triggering transaction | ||||||
Type of financialinstrument | Exercise price | Expiration date xvii | Exercise/Conversion period xviii | Number of voting rights instrument refers to
| % of voting rights xix, xx
| |
|
|
|
|
| Nominal | Delta |
|
|
Total (A+B+C) | |
Number of voting rights | Percentage of voting rights |
23,525,128 | 3.86% |
9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi | ||
The voting rights are managed and controlled by Aviva Investors Global Services Limited, with the following chain of controlled undertakings:-
Aviva Investors Global Services Limited: · Aviva plc (Parent Company) · Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc) · Aviva Investors Holdings Limited (wholly owned subsidiary of Aviva Group Holdings Limited) · Aviva Investors Global Services Limited (wholly owned subsidiary of Aviva Investors Holdings Limited)
| ||
| ||
Proxy Voting: | ||
10. Name of the proxy holder: | See Section 4 | |
11. Number of voting rights proxy holder will ceaseto hold: |
| |
12. Date on which proxy holder will cease to holdvoting rights: |
| |
| ||
13. Additional information: | Figures are based on a total number of voting rights of 608,962,519 as per the Company's 'Total Voting Rights and Capital' announcement of 01 September 2016.
| |
14. Contact name: | Neil Whittaker, Aviva plc | |
15. Contact telephone number: | 01603 684420 | |
Related Shares:
AA..LAviva